
CRIS vs DNA
$CRIS vs $DNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
CRIS vs DNA: the quick read
- ·DNA is the larger company by market cap ($760M vs $2M).
- ·DNA has been more active on our scanner (220 vs 121 alerts in 30 days).
- ·CRIS has the smaller float (2.4M vs 67.3M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·CRIS trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 220 and 121 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: DNA is more than 346x the market cap of CRIS, so the same dollar of news moves CRIS far harder.
- ·They are pulling apart today: DNA is outperforming the other by roughly 14.6 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing CRIS and DNA on TheDesperateTrader.
- Is CRIS or DNA the better stock?
- "Better" depends on your goal, and these two are not alike. DNA is the larger company by market cap ($760M vs $2M). DNA has been more active on our scanner (220 vs 121 alerts in 30 days). CRIS has the smaller float (2.4M vs 67.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between CRIS and DNA?
- The differences that matter: DNA is roughly 346x the size of the other by market cap ($2M vs $760M); they trade at very different share prices ($0.78 vs $11.39); CRIS sits at 9% of its 52-week range against 47% for DNA; our scanner flagged CRIS 121 times in the last 30 days against 220 for DNA. Everything above is measured from the latest completed session and SEC filings.
- Which of CRIS and DNA is more active right now?
- Right now CRIS is at about 0.4x its normal volume and DNA is at about 0.9x, so DNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading CRIS or DNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore CRIS and DNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.